Baseline hypertension, ASIs affect hypertension, survival during VEGF inhibitor therapy
Baseline hypertension and BMI can affect worsening hypertension among patients administered vascular endothelial growth factor signaling pathway inhibitors, according to research presented at the 2014 ASCO Annual Meeting.
